166
Views
0
CrossRef citations to date
0
Altmetric
Review Articles

Perimenopause in women with rheumatologic diseases: a spotlight on an under-addressed transition

ORCID Icon
Pages 115-121 | Received 22 Jun 2023, Accepted 24 Oct 2023, Published online: 22 Nov 2023

References

  • Sowers MF, Crawford SL, Sternfeld B, et al. SWAN: a multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, editors. Menopause: biology and pathobiology. San Diego: Academic Press; 2000. p. 175.
  • Freeman EW, Sammel MD. Methods in a longitudinal cohort study of late reproductive age women: the Penn Ovarian Aging Study (POAS). Womens Midlife Health. 2016;2(1):1. doi: 10.1186/s40695-016-0014-2.
  • Santoro N. Perimenopause: from research to practice. J Womens Health (Larchmt). 2016;25(4):332–339. doi: 10.1089/jwh.2015.5556.
  • Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5(1):e8772. doi: 10.1371/journal.pone.0008772.
  • Santoro N, Crawford SL, El Khoudary SR, et al. Menstrual cycle hormone changes in women traversing menopause: study of women’s health across the nation. J Clin Endocrinol Metab. 2017;102(7):2218–2229. doi: 10.1210/jc.2016-40176.
  • Multiple A. Management of menopausal symptoms. Am J Med. 2005;118:1–171. doi: 10.1097/AOG.0000000000001058.
  • Harper JC, Phillips S, Biswakarma R, et al. An online survey of perimenopausal women to determine their attitudes and knowledge of the menopause. Womens Health (Lond). 2022;18:17455057221106890. doi: 10.1177/17455057221106890.
  • Suarez-García I, Alejos B, Pérez-Elías MJ, et al. How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort. BMC Womens Health. 2021;21(1):223. doi: 10.1186/s12905-021-01370-w.
  • Avis NE, Colvin A, Karlamangla AS, et al. Change in sexual functioning over the menopausal transition: results from the Study of Women’s Health across the Nation. Menopause. 2017;24(4):379–390. doi: 10.1097/GME.0000000000000770.
  • LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049–2102. doi: 10.1007/s00198-021-05900-y11.
  • Lurati AR. Effects of menopause on appetite and the gastrointestinal system. Nurs Womens Health. 2018;22(6):499–505.
  • Newson L. Menopause and cardiovascular disease. Post Reprod Health. 2018;24(1):44–49. doi: 10.1177/2053369117749675.
  • Calleja-Agius J, Brincat M. The effect of menopause on the skin and other connective tissues. Gynecol Endocrinol. 2012;28(4):273–277. doi: 10.3109/09513590.2011.613970.
  • Angelou K, Grigoriadis T, Diakosavvas M, et al. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020;12(4):e7586. doi: 10.7759/cureus.7586.
  • Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol. 2018;9:2279. doi: 10.3389/fimmu.2018.02279.
  • Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecol Endocrinol. 2014;30(1):16–22. doi: 10.3109/09513590.2013.852531.
  • Talsania M, Scofield RH. Menopause and rheumatic disease. Rheum Dis Clin North Am. 2017;43(2):287–302. doi: 10.1016/j.rdc.2016.12.011.
  • Desai MK, Brinton RD. Autoimmune disease in women: endocrine transition and risk across the lifespan. Front Endocrinol (Lausanne). 2019;10:265. doi: 10.3389/fendo.2019.00265.
  • Chen Y, Zhang Y, Zhao G, et al. Difference in leukocyte composition between women before and after menopausal age, and distinct sexual dimorphism. PLoS One. 2016;11(9):e0162953. doi: 10.1371/journal.pone.0162953.
  • Angum F, Khan T, Kaler J, et al. The prevalence of autoimmune disorders in women: a narrative review. Cureus. 2020;12(5):e8094. doi: 10.7759/cureus.8094.
  • Huret C, David A, Mohamed M, et al. Altered X-chromosome inactivation predisposes to autoimmune manifestations in mice. bioRxiv. 2023. doi: 10.1101/2023.04.20.537662.
  • Zen M, Salmaso L, Barbiellini Amidei C, et al. Systemic lupus erythematosus incidence and prevalence in a large population-based study in northeastern Italy. Rheumatology (Oxford). 2023;62(8):2773–2779. doi: 10.1093/rheumatology/keac685.
  • Urowitz MB, Ibañez D, Jerome D, et al. The effect of menopause on disease activity in systemic lupus erythematosus. J Rheumatol. 2006;33:2192–2198.
  • Ma S, Wang C, Mao X, et al. B cell dysfunction associated with aging and autoimmune diseases. Front Immunol. 2019;10:318. doi: 10.3389/fimmu.2019.00318.
  • Sammaritano LR. Menopause in patients with autoimmune diseases. Autoimmun Rev. 2012;11(6–7):A430–A436. doi: 10.1016/j.autrev.2011.11.006.
  • Gersh FL, O’Keefe JH, Lavie CJ, et al. The Renin-Angiotensin-Aldosterone system in postmenopausal women: the promise of hormone therapy. Mayo Clin Proc. 2021;96(12):3130–3141. doi: 10.1016/j.mayocp.2021.08.009.
  • Marder W, Vinet É, Somers EC. Rheumatic autoimmune diseases in women and midlife health. Womens Midlife Health. 2015;1(1):11. doi: 10.1186/s40695-015-0012-9.
  • Kerola AM, Sexton J, Wibetoe G, et al. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway. Semin Arthritis Rheum. 2021;51(5):1081–1088. doi: 10.1016/j.semarthrit.2021.08.006.
  • Bove R. Autoimmune diseases and reproductive aging. Clin Immunol. 2013;149(2):251–264. doi: 10.1016/j.clim.2013.02.010.
  • Pikwer M, Nilsson JA, Bergstrom U, et al. Early menopause and severity of rheumatoid arthritis in women older than 45 years. Arthritis Res Ther. 2012;14(4):R190. doi: 10.1186/ar4021.
  • Beydoun HA, el-Amin R, McNeal M, et al. Reproductive history and postmenopausal rheumatoid arthritis among women 60 years or older: Third National Health and Nutrition Examination Survey. Menopause. 2013;20(9):930–935. doi: 10.1097/GME.0b013e3182a14372.
  • Mollard E, Pedro S, Chakravarty E, et al. The impact of menopause on functional status in women with rheumatoid arthritis. Rheumatology (Oxford). 2018;57(5):798–802. doi: 10.1093/rheumatology/kex526.
  • Wu M, Chen G, Li YP. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016;4(1):16009. Published 2016 Apr 26. doi: 10.1038/boneres.2016.9.
  • Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989–2003. doi: 10.1056/NEJMra0806188.
  • Soldano S, Montagna P, Brizzolara R, et al. Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. Ann N Y Acad Sci. 2010;1193(1):25–29. doi: 10.1056/NEJMra0806188.
  • Vinet E, Bernatsky S, Hudson M, et al. Effect of menopause on the modified Rodnan skin score in systemic sclerosis. Arthritis Res Ther. 2014;16(3):R130. doi: 10.1186/ar4587.
  • Morrisroe K, Huq M, Stevens W, et al. Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study. BMC Pulm Med. 2016;16(1):134. doi: 10.1186/s12890-016-0296-z.
  • Cannarile F, Valentini V, Mirabelli G, et al. Cardiovascular disease in systemic sclerosis. Ann Transl Med. 2015;3(1):8. doi: 10.3978/j.issn.2305-5839.2014.12.12.
  • Leza JC. Fibromialgia: un reto también Para la neurociencia. Rev Neurol. 2003;36(12):1165–1175.
  • Dias RCA, Kulak Junior J, Ferreira da Costa EH, et al. Fibromyalgia, sleep disturbance and menopause: is there a relationship? A literature review. Int J Rheum Dis. 2019;22(11):1961–1971. doi: 10.1111/1756-185X.13713.
  • Neyro JL, Franco R, Rodríguez E, et al. Fibromyalgia and menopause. Ginecol Obstet Mex. 2011;79(9):572–578.
  • Carranza-Lira S, Hernandez IB. Prevalence of fibromyalgia in premenopausal and postmenopausal women and its relation to climacteric symptoms. Prz Menopauzalny. 2014;13(3):169–173. doi: 10.5114/pm.2014.43819.
  • Watt FE. Musculoskeletal pain and menopause. Post Reprod Health. 2018;24(1):34–43. doi: 10.1177/205336911875753743.
  • Mostafa H, Radwan A. The relationship between disease activity and depression in Egyptian patients with rheumatoid arthritis. The Egyptian Rheumatologist. 2013;35:193–199. doi: 10.1016/j.ejr.2013.05.001.
  • Son MK, Lim NK, Lim JY, et al. Difference in blood pressure between early and late menopausal transition was significant in healthy Korean women. BMC Womens Health. 2015;15:64. doi: 10.1186/s12905-015-0219-9.
  • Kozakowski J, Gietka-Czernel M, Leszczyńska D, et al. Obesity in menopause – our negligence or an unfortunate inevitability? Prz Menopauzalny. 2017; Jun16(2):61–65. doi: 10.5114/pm.2017.68594.
  • Aspray TJ, Hill TR. Osteoporosis and the ageing skeleton. Subcell Biochem. 2019;91:453–476. doi: 10.1007/978-981-13-3681-2_16.
  • Gale S, Wilson JC, Chia J, et al. Risk associated with cumulative oral glucocorticoid use in patients with giant cell arteritis in real-world databases from the USA and UK. Rheumatol Ther. 2018;5(2):327–340. doi: 10.1007/s40744-018-0112-8.
  • Marcum ZA, Hanlon JT. Recognizing the risks of chronic nonsteroidal anti-Inflammatory drug use in older adults. Ann Longterm Care. 2010;18(9):24–27.
  • Kerola AM, Rollefstad S, Semb AG. Atherosclerotic cardiovascular disease in rheumatoid arthritis: impact of inflammation and antirheumatic treatment. Eur Cardiol. 2021; May 1316:e18. doi: 10.15420/ecr.2020.44.
  • Dehghani T, Panitch A. Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle. Open Biol. 2020;10(10):200161. doi: 10.1098/rsob.200161.
  • Smith PJ, Blumenthal JA, Hinderliter AL, et al. Microvascular endothelial function and neurocognition among adults with major depressive disorder. Am J Geriatr Psychiatry. 2018;26(10):1061–1069. doi: 10.1016/j.jagp.2018.06.011.
  • Fraenkel L, Bathon JM, England BR, et al. 2021 American college of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924–939. doi: 10.1002/acr.24596.
  • Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18. doi: 10.1136/ard-2022-223356.
  • Weinblatt ME. Methotrexate: who would have predicted its importance in rheumatoid arthritis? Arthritis Res Ther. 2018;20(1):103. doi: 10.1186/s13075-018-1599-7.
  • Melsheimer R, Geldhof A, Apaolaza I, et al. Remicade® (infliximab): 20 years of contributions to science and medicine. Biologics. 2019;13:139–178. doi: 10.2147/BTT.S207246.
  • Dijkshoorn B, Raadsen R, Nurmohamed MT. Cardiovascular disease risk in rheumatoid arthritis anno 2022. J Clin Med. 2022;11(10):2704. doi: 10.3390/jcm11102704.
  • Chen JF, Hsu CY, Yu SF, et al. The impact of long-term biologics/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis. Rheumatology (Oxford). 2020;59(9):2471–2480. doi: 10.3390/jcm1110270458.
  • Mysler E, Caubet M, Lizarraga A. Current and emerging DMARDs for the treatment of rheumatoid arthritis. OARRR. 2021;13:139–152. doi: 10.2147/OARRR.S282659.
  • Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 Update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745. doi: 10.1136/annrheumdis-2019-215089.
  • Connolly MK. Systemic sclerosis (scleroderma): remaining challenges. Ann Transl Med. 2021;9(5):438–438. doi: 10.21037/atm-20-5449.
  • Sharma C, Whittle S, Haghighi PD, et al. Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis. Ann Rheum Dis. 2020;79(11):1432–1437. doi: 10.1136/annrheumdis-2020-217333.
  • Xu YH, Zhu WM, Guo Z. Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease. World J Gastroenterol. 2022;28(48):6888–6899. doi: 10.3748/wjg.v28.i48.6888.
  • Gargano G, Oliva F, Oliviero A, et al. Small interfering RNAs in the management of human rheumatoid arthritis. Br Med Bull. 2022;142(1):34–43. doi: 10.1093/bmb/ldac012.
  • Davis JS, Ferreira D, Paige E, et al. Infectious complications of biological and small molecule targeted immunomodulatory therapies. Clin Microbiol Rev. 2020;33(3):e00035. Published 2020 Jun 10. doi: 10.1128/CMR.00035-19.
  • Mulhearn B, Barton A, Viatte S. Using the immunophenotype to predict response to biologic drugs in rheumatoid arthritis. J Pers Med. 2019;9(4):46. doi: 10.3390/jpm9040046.
  • Tzadok R, Ablin JN. Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manag. 2020;2020:6541798–6541799. doi: 10.1155/2020/6541798.
  • Mehta J, Kling JM, Manson JE. Risks, benefits, and treatment modalities of menopausal hormone therapy: current concepts. Front Endocrinol (Lausanne). 2021;12:564781. doi: 10.3389/fendo.2021.564781.
  • Files JA, Ko MG, Pruthi S. Bioidentical hormone therapy. Mayo Clin Proc. 2011;86(7):673–680, quiz 680. doi: 10.4065/mcp.2010.0714.
  • Soares JM, JrEspósito Sorpreso IC, Nunes Curado JF, et al. Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review. Climacteric. 2022;25(5):427–433. doi: 10.1080/13697137.2022.2050205.
  • Favalli EG, Biggioggero M, Crotti C, et al. Sex and management of rheumatoid arthritis. Clin Rev Allergy Immunol. 2019;56(3):333–345. doi: 10.1007/s12016-018-8672-5.
  • Daraghmeh DN, Hopkins AM, King C, et al. Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs. Rheumatology (Oxford). 2023;62(2):583–595. doi: 10.1093/rheumatology/keac357.
  • Ciaffi J, van Leeuwen NM, Schoones JW, et al. Sex hormones and sex hormone-targeting therapies in systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2020;50(1):140–148. doi: 10.1016/j.semarthrit.2019.07.007.
  • Patasova K, Dehara M, Arkema E, et al. Hormone replacement therapy increases the risk of systemic sclerosis: results from large population-based control study. Ann Rheum Dis. 2023;82:1013–1014.
  • Dias RC, Costa EH, Chrisostomo KR, et al. Fibromyalgia and menopause: an open study on postmenopausal hormone therapy. Minerva Obstet Gynecol. 2023;75(5):424–431. doi: 10.23736/S2724-606X.22.05085-0.
  • Ozcivit IB, Erel CT, Durmusoglu F. Can fibromyalgia be considered a characteristic symptom of climacterium? Postgrad Med J. 2023;99(1170):244–251. doi: 10.1136/postgradmedj-2021-140336.
  • Maas AH, Franke HR. Women’s health in menopause with a focus on hypertension. Neth Heart J. 2009;17(2):68–72. doi: 10.1007/BF03086220.
  • Maas AHEM, Rosano G, Cifkova R, et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists [published correction appears in Eur Heart J. 2022 Jul 1;43(25):2372]. Eur Heart J. 2021;42(10):967–984. doi: 10.1093/eurheartj/ehaa1044.
  • Zanchetti A, Facchetti R, Cesana GC, et al. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens. 2005;23(12):2269–2276. doi: 10.1097/01.hjh.0000194118.35098.43.
  • Real RD, Aguino NM. Treatment of arterial hypertension in menopause. An Fac Cienc Méd. 2018;51(1):65–74. doi: 10.18004/anales/2018.051(01)65-074.
  • Lee JS, Hayashi K, Mishra G, et al. Independent association between age at natural menopause and hypercholesterolemia, hypertension, and diabetes mellitus: Japan nurses’ health study. J Atheroscler Thromb. 2013;20(2):161–169. doi: 10.5551/jat.14746.
  • Ghazi L, Annabathula RV, Bello NA, et al. Hypertension across a Woman’s Life Cycle. Curr Hypertens Rep. 2022;24(12):723–733. doi: 10.1007/s11906-022-01230-4.
  • Ikeda H, Inoue T, Uemura S, et al. Effects of candesartan for Middle-aged and elderly women with hypertension and menopausal-like symptoms. Hypertens Res. 2006; Dec29(12):1007–1012. doi: 10.1291/hypres.29.1007.
  • Nagy Z, Szigedi E, Takács S, et al. The effectiveness of psychological interventions for rheumatoid arthritis (RA): a systematic review and meta-analysis. Life (Basel). 2023;13(3):849. doi: 10.3390/life13030849.
  • Pardos-Gascón EM, Narambuena L, Leal-Costa C, et al. Differential efficacy between cognitive-behavioral therapy and mindfulness-based therapies for chronic pain: systematic review. Int J Clin Health Psychol. 2021;21(1):100197. doi: 10.1016/j.ijchp.2020.08.001.
  • Sosa-Reina MD, Nunez-Nagy S, Gallego-Izquierdo T, et al. Effectiveness of therapeutic exercise in fibromyalgia syndrome: a systematic review and meta-analysis of randomized clinical trials. Biomed Res Int. 2017;2017:2356314–2356346. doi: 10.1155/2017/2356346.
  • Flachenecker P. Autoimmune diseases and rehabilitation. Autoimmun Rev. 2012;11(3):219–225. doi: 10.1016/j.autrev.2011.05.016.
  • McMurray RW, May W. Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum. 2003;48(8):2100–2110. doi: 10.1002/art.11105.
  • Royle JG, Lanyon PC, Grainge MJ, et al. The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink [published correction appears in Clin Rheumatol. 2018 Sep;37(9):2601]. Clin Rheumatol. 2018;37(8):2103–2111. doi: 10.1007/s10067-018-4182-3.
  • Eder L, Haddad A, Rosen CF, et al. The Incidence and Risk Factors for Psoriatic Arthritis in Patients With Psoriasis: A Prospective Cohort Study. Arthritis Rheumatol. 2016;68(4):915–923. doi: 10.1002/art.39494.
  • Danesh M, Murase JE. The immunologic effects of estrogen on psoriasis: A comprehensive review. Int J Womens Dermatol. 2015;1(2):104–107. doi: 10.1016/j.ijwd.2015.03.001.
  • Ceovic R, Mance M, Bukvic Mokos Z, et al. Psoriasis: female skin changes in various hormonal stages throughout life–puberty, pregnancy, and menopause. Biomed Res Int. 2013;2013:571912. doi: 10.1155/2013/571912.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.